Pleasanton, Calif. – September 19, 2026 -- Healthcare Triangle, Inc. (Nasdaq: HCTI) has signed on as the U.S. technology and capital-markets partner for the newly launched Kanzun-ARCB Growth Fund, a vehicle designed to move Malaysian healthcare companies toward Middle Eastern capital and, ultimately, U.S. capital markets.
ARCB and Kanzun formalize the fund via a Kuala Lumpur MOU
The Kanzun-ARCB Growth Fund launched through a Memorandum of Understanding signed in Kuala Lumpur, pairing Dubai-based ARCB Investment LLC's capital network with Kanzun Ventures Management Sdn. Bhd.'s deal execution in Malaysia. ARCB opened its Asia-Pacific office in Kuala Lumpur in April 2026, and this fund represents its first major platform launch in the region.
ARCB brings roughly AED 300 million in assets under management
ARCB's AUM spans a network of family offices, institutional investors and strategic partners across the Middle East and Asia. The firm already manages capital across ten sectors, including energy, water, healthcare, education and technology.
Three-party structure divides sourcing, capital and U.S. market readiness
Kanzun will lead deal sourcing, due diligence, valuation and portfolio development within Malaysia, identifying healthcare companies with growth potential. ARCB anchors capital formation through its investor base. HCTI's role begins once target companies reach their next growth stage, applying its Nasdaq-listed experience and expertise in artificial intelligence, cloud, data and digital infrastructure to build the technology foundation required for U.S. expansion.
Executives frame the fund as a corridor, not a one-off deal
Dr Suresh Venkatachari, Founder and Head of M&A at Healthcare Triangle, said the company will support qualifying Malaysian firms in their AI technology transformation while evaluating strategic pathways for U.S. market expansion. ARCB Group CEO Dr Chaskar U. described the initiative as building "a corridor that connects Malaysian healthcare champions to Middle Eastern capital and, from there, to the U.S. capital markets,